Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2021-03-15 (5 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROUBAIX (59100), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE V.VANHOVE : revenue, balance sheet and financial ratios
SELAS PHARMACIE V.VANHOVE is a French company
founded 5 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROUBAIX (59100),
this company of category PME
shows in 2024 a net income negative of -15 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE V.VANHOVE (SIREN 894678002)
Indicator
2024
2023
2021
Revenue
N/C
N/C
N/C
Net income
-14 656 €
651 €
32 189 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2024, SELAS PHARMACIE V.VANHOVE records a net loss of 15 k€. This deficit will reduce equity on the balance sheet.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-14 656 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 322%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
321.645%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
19.246%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2023
2024
Debt ratio
670.724
321.488
321.645
Financial autonomy
10.643
19.508
19.246
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
321.642024
2021
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of SELAS PHARMACIE V.VANHOVE (321.64) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
19.25%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of SELAS PHARMACIE V.VANHOVE (19.2%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 194.33. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2023
2024
Liquidity ratio
172.45
228.025
194.327
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
194.332024
2021
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good+13 pts over 3 years
In 2024, the liquidity ratio of SELAS PHARMACIE V.VANHOVE (194.33) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of SELAS PHARMACIE V.VANHOVE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE V.VANHOVE with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE V.VANHOVE
What is the revenue of SELAS PHARMACIE V.VANHOVE ?
The revenue of SELAS PHARMACIE V.VANHOVE is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE V.VANHOVE profitable?
SELAS PHARMACIE V.VANHOVE recorded a net loss in 2024.
Where is the headquarters of SELAS PHARMACIE V.VANHOVE ?
The headquarters of SELAS PHARMACIE V.VANHOVE is located in ROUBAIX (59100), in the department Nord.
Where to find the tax return of SELAS PHARMACIE V.VANHOVE ?
The tax return of SELAS PHARMACIE V.VANHOVE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE V.VANHOVE operate?
SELAS PHARMACIE V.VANHOVE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart